FibroGen Inc (NASDAQ: FGEN) is 123.40% higher on its value in year-to-date trading and has touched a low of $0.33 and a high of $22.44 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The FGEN stock was last observed hovering at around $1.83 in the last trading session, with the day’s gains setting it 0.15%.
Currently trading at $1.98, the stock is -4.06% and 41.23% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.52 million and changing 8.20% at the moment leaves the stock -41.80% off its SMA200. FGEN registered -91.09% loss for a year compared to 6-month gain of 106.25%. The firm has a 50-day simple moving average (SMA 50) of $0.65 and a 200-day simple moving average (SMA200) of -$0.37.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -16.46% loss in the last 1 month and extending the period to 3 months gives it a 258.44%, and is 7.03% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 20.19% over the week and 19.56% over the month.
FibroGen Inc (FGEN) has around 486 employees, a market worth around $195.56M and $147.75M in sales. Profit margin for the company is -192.37%. Distance from 52-week low is 494.06% and -91.18% from its 52-week high.
FibroGen Inc quarterly earnings per share for the current quarter are estimated at -$0.41 with sales reaching $36.45M over the same period.The EPS is expected to grow by 55.71% this year, but quarterly earnings will post 7.20% year-over-year. Quarterly sales are estimated to grow 14.50% in year-over-year returns.
FibroGen Inc (FGEN) Top Institutional Holders
130 institutions hold shares in FibroGen Inc (FGEN), with institutional investors hold 76.23% of the company’s shares. The shares outstanding are 98.77M, and float is at 91.81M with Short Float at 7.85%. Institutions hold 71.51% of the Float.
The top institutional shareholder in the company is Primecap Management Company with over 13.68 million shares valued at $36.93 million. The investor’s holdings represent 13.93% of the FGEN Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 9.74 million shares valued at $26.3 million to account for 9.92% of the shares outstanding. The other top investors are Blackrock Inc. which holds 8.98 million shares representing 9.15% and valued at over $24.25 million, while State Street Corporation holds 5.11% of the shares totaling 5.01 million with a market value of $13.54 million.
FibroGen Inc (FGEN) Insider Activity
A total of 8 insider transactions have happened at FibroGen Inc (FGEN) in the last six months, with sales accounting for 8 and purchases happening 0 times. The most recent transaction is an insider sale by Henderson Jeffrey William,the company’sDirector. SEC filings show that Henderson Jeffrey William sold 2,000 shares of the company’s common stock on Sep 01 at a price of $1.03 per share for a total of $2060.0. Following the sale, the insider now owns 28866.0 shares.
FibroGen Inc disclosed in a document filed with the SEC on Aug 04 that Henderson Jeffrey William (Director) sold a total of 2,000 shares of the company’s common stock. The trade occurred on Aug 04 and was made at $1.91 per share for $3820.0. Following the transaction, the insider now directly holds 30866.0 shares of the FGEN stock.
Still, SEC filings show that on Jul 11, Henderson Jeffrey William (Director) disposed off 2,000 shares at an average price of $2.69 for $5380.0. The insider now directly holds 32,866 shares of FibroGen Inc (FGEN).
FibroGen Inc (FGEN): Who are the competitors?
The company’s main competitors (and peers) include Harvard Bioscience Inc. (HBIO) that is trading 74.10% up over the past 12 months. Illumina Inc. (ILMN) that is -36.14% lower over the same period.
